Bhekisisa

The United States government has appointed the first African head of its Aids fund, Pepfar. John Nkengasong, a Cameroonian virologist with US citizenship, will need to establish the potential impact of America’s change in abortion legislation on Pepfar funding rules.

A cheap antibiotic (called doxycycline) used to treat skin infections and to stop people from getting malaria could also work to prevent chlamydia, gonorrhoea and syphilis, found a United States study in men who have sex with men and transgender women.

Researchers have found that 96% of global health conferences happen in high- or middle-income countries. Less than four in 10 attendees at these gatherings are from poorer nations that have the highest burden of disease.

Researchers have found that 96% of global health conferences happen in high- or middle-income countries. Less than four in 10 attendees at these gatherings are from poorer nations that have the highest burden of disease.

Forty-four new National Health Insurance (NHI) positions, based at the national health department head office in Tshwane, will be advertised in the coming weeks and filled by January 2023.

Mia and Ayoade Alakija discuss the 2022 International Aids conference and how institutional racism in the global health system affects who gets to have a say in the fight against HIV/AIDS. A South African NGO is helping teen moms to stay in school, we bring you their stories. Finally we unpack how the South African government is going to hire experts to implement universal healthcare policy.

One in four South African medical students show signs of depression, and most doctors are at risk of burning out. Read about one state doctor’s road to hell and back again.

A two-monthy HIV prevention injection could be too expensive for the department of health to buy even though the country participated in drug trials...

When South Africa introduced self-tests for HIV, far more people knew their status and were put on treatment. The same could happen for cervical cancer, argues this cancer advocate, and the country already has the networks, testing capacity and funding in place to make a project like this work.

Germs are outsmarting medicine faster than South Africa’s overburdened facilities can keep up with. There are ways to cut resistance, but such plans need more money for them to work.